record initialized not assigned to examiner
on 27 Mar 2024
Last Applicant/ Owned by
55 Cambridge Parkway, Suite 800E
Cambridge
MA
02142
Serial Number
98471040 filed on 27th Mar 2024
Registration Number
N/A
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical, medical, scientific, and biopharmaceutical research and development; consulting services for others in the field of design, planning, and implementation project management of clinical trials; technical consulting in the field of pharmaceutical studies; consulting services in the field of pharmaceutical research and development; providing on-line non-downloadable software using artiRead More
Pharmaceutical, medical, scientific, and biopharmaceutical research and development; consulting services for others in the field of design, planning, and implementation project management of clinical trials; technical consulting in the field of pharmaceutical studies; consulting services in the field of pharmaceutical research and development; providing on-line non-downloadable software using artificial intelligence, computational methods, and machine learning models for the design and characterization of therapeutic products and drug analysis in the field of drug discovery and development; product development for others in the field of biotechnology and development of pharmaceuticals and therapeutic agents; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for others; research and development of therapeutics related to the discovery, capture, and analysis of data in the field of drug development; providing scientific laboratory services for the discovery, capture, and analysis of data in the field of drug development
Custom manufacture of pharmaceuticals
No 98471040
No Service Mark
No F09182000000
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 27th Mar 2024 | NEW APPLICATION ENTERED |
